Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Innerscope Hearing Technologies's enterprise value is $0.04 Mil.
Innerscope Hearing Technologies's EBITDA for the trailing twelve months (TTM) ended in Dec. 2020 was $-3.73 Mil. Therefore, Innerscope Hearing Technologies's EV-to-EBITDA for today is -0.01.
The historical rank and industry rank for Innerscope Hearing Technologies's EV-to-EBITDA or its related term are showing as below:
INND'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -0.01 Med: 0 Max: 0
Current: -0.01
INND's EV-to-EBITDA is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 14.83
vs INND: -0.01
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Innerscope Hearing Technologies's PE Ratio (TTM) for today is calculated as:
Innerscope Hearing Technologies's share price for today is $0.0001.
Innerscope Hearing Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.591.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Innerscope Hearing Technologies's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Innerscope Hearing Technologies EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Innerscope Hearing Technologies's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Innerscope Hearing Technologies's EV-to-EBITDA falls into.
Innerscope Hearing Technologies's current Enterprise Value is $0.04 Mil.
Innerscope Hearing Technologies's EBITDA for the trailing twelve months (TTM) ended in Dec. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.73 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Innerscope Hearing Technologies (INND) has a EV-to-EBITDA of -0.01 as of Aug. 18, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Innerscope Hearing Technologies.
Is Innerscope Hearing Technologies' EV-to-EBITDA too high?
Innerscope Hearing Technologies' current EV-to-EBITDA is -0.01.
How does Innerscope Hearing Technologies' EV-to-EBITDA compare to NWCN and NCAP?
Innerscope Hearing Technologies' EV-to-EBITDA of -0.01 can be compared against companies in the Medical Devices & Instruments industry. The industry median EV-to-EBITDA is 14.83. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.83, based on 513 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Innerscope Hearing Technologies. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Innerscope Hearing Technologies's current EV-to-EBITDA is -0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innerscope Hearing Technologies stock overvalued right now?
Innerscope Hearing Technologies (INND) has a current EV-to-EBITDA of -0.01. The current EV-to-EBITDA is -0.01. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Innerscope Hearing Technologies (INND), the current EV-to-EBITDA is -0.01 as of Aug. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Innerscope Hearing Technologies Inc is a manufacturer and distributor of OTC Hearing Aids, Hearing Aid Accessories & Hearing Health-Related Products (Hearing Products) dedicated to addressing the demand for affordable hearing solutions. The company operates retail hearing device clinics in California. InnerScope is focused on leveraging these strategic assets to identify, incubate, and support health-technology ventures positioned for growth in public markets and long-term shareholder value creation.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
INND has been successfully added to your 
